Literature DB >> 23836040

Perspectives on human clinical trials of therapies using iPS cells in Japan: reaching the forefront of stem-cell therapies.

Peipei Song1, Yoshinori Inagaki, Yasuhiko Sugawara, Norihiro Kokudo.   

Abstract

A research project involving sheets of retinal pigment epithelium constructed from iPS cells derived from patients with age-related maculopathy is one step closer to being approved for clinical trials by the Japanese Government. Now is the time to make therapies using iPS cells clinically available.

Entities:  

Mesh：

Year:  2013        PMID： 23836040

Source DB:  PubMed          Journal:  Biosci Trends        ISSN： 1881-7815            Impact factor:   2.400


  10 in total

1.  Enhancing RPE Cell-Based Therapy Outcomes for AMD: The Role of Bruch's Membrane.

Authors:  Janosch P Heller; Keith R Martin
Journal:  Transl Vis Sci Technol       Date:  2014-07-03       Impact factor: 3.283

2.  Biobanking of Human Retinas: The Next Big Leap for Eye Banks?

Authors:  Zala Lužnik; Mohit Parekh; Marina Bertolin; Carlo Griffoni; Diego Ponzin; Stefano Ferrari
Journal:  Stem Cells Transl Med       Date:  2015-06-01       Impact factor: 6.940

3.  Activated adult microglia influence retinal progenitor cell proliferation and differentiation toward recoverin-expressing neuron-like cells in a co-culture model.

Authors:  Yunhe Xu; Balini Balasubramaniam; David A Copland; Jian Liu; M John Armitage; Andrew D Dick
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-02-14       Impact factor: 3.117

4.  The potential of stem cell-based therapy for retinal repair.

Authors:  Honghua Yu; Lin Cheng; Kin-Sang Cho
Journal:  Neural Regen Res       Date:  2014-06-01       Impact factor: 5.135

Review 5.  Human induced pluripotent stem cells for monogenic disease modelling and therapy.

Authors:  Paola Spitalieri; Valentina Rosa Talarico; Michela Murdocca; Giuseppe Novelli; Federica Sangiuolo
Journal:  World J Stem Cells       Date:  2016-04-26       Impact factor: 5.326

6.  In situ regeneration of retinal pigment epithelium by gene transfer of E2F2: a potential strategy for treatment of macular degenerations.

Authors:  D Kampik; M Basche; U F O Luhmann; K M Nishiguchi; J A E Williams; J Greenwood; S E Moss; H Han; S Azam; Y Duran; S J Robbie; J W B Bainbridge; D F Larkin; A J Smith; R R Ali
Journal:  Gene Ther       Date:  2017-11-30       Impact factor: 5.250

7.  Countries' Biomedical Publications and Attraction Scores. A PubMed-based assessment.

Authors:  Qinyi Xu; Andrea Boggio; Andrea Ballabeni
Journal:  F1000Res       Date:  2014-12-01

8.  Stem Cell Differentiation and Therapeutic Use.

Authors:  Matthew S Alexander; Juan Carlos Casar; Norio Motohashi
Journal:  Stem Cells Int       Date:  2015-08-04       Impact factor: 5.443

9.  Generation of clinical-grade human induced pluripotent stem cells in Xeno-free conditions.

Authors:  Juan Wang; Jie Hao; Donghui Bai; Qi Gu; Weifang Han; Lei Wang; Yuanqing Tan; Xia Li; Ke Xue; Pencheng Han; Zhengxin Liu; Yundan Jia; Jun Wu; Lei Liu; Liu Wang; Wei Li; Zhonghua Liu; Qi Zhou
Journal:  Stem Cell Res Ther       Date:  2015-11-12       Impact factor: 6.832

Review 10.  Role of the Hedgehog Signaling Pathway in Regulating the Behavior of Germline Stem Cells.

Authors:  Shiqin Li; Meng Wang; Yanghui Chen; Wei Wang; Junying Wu; Chengpeng Yu; Yuehui Zheng; Zezheng Pan
Journal:  Stem Cells Int       Date:  2017-08-13       Impact factor: 5.443
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.